Position in HAE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,477,550
+$3,746,848 QoQ
Shares Held
73,034
+137.8% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 329 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HAE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $1,013,353,919 across 58 Medical Devices names. HAE ranks #21 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
|
5,469,698 | $209,708,221 | |
| 2 | EW |
Edwards Lifesciences Corp
|
1,252,407 | $113,292,737 | |
| 3 | GMED |
Globus Medical Inc
|
1,219,098 | $96,320,932 | |
| 4 | ABT |
Abbott Laboratories
|
788,559 | $71,553,843 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
722,139 | $62,168,946 | |
| 6 | SYK |
Stryker Corp
|
173,466 | $54,614,035 | |
| 7 | MDT |
Medtronic plc
|
631,667 | $49,415,309 | |
| 8 | PODD |
Insulet Corp
|
316,922 | $48,251,374 |
All Filings in HAE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,477,550 | 73,034 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,730,702 | 30,708 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $457,496 | 5,708 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $232,830 | 4,777 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $260,538 | 3,492 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $203,550 | 3,203 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||